Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Sarah Leist and Ralph Baric.
Sarah Leist
Connection Strength
5.401
Ralph Baric
  1. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 2020 11 12; 183(4):1070-1085.e12.
    View in: PubMed
    Score: 0.904
  2. Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections. Trends Genet. 2018 10; 34(10):777-789.
    View in: PubMed
    Score: 0.782
  3. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 2021 08 27; 373(6558):991-998.
    View in: PubMed
    Score: 0.238
  4. Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 2021 Feb; 590(7844):E22.
    View in: PubMed
    Score: 0.232
  5. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science. 2020 12 18; 370(6523):1464-1468.
    View in: PubMed
    Score: 0.228
  6. Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26915-26925.
    View in: PubMed
    Score: 0.227
  7. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 2020 10; 586(7830):560-566.
    View in: PubMed
    Score: 0.225
  8. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020 07 23; 182(2):429-446.e14.
    View in: PubMed
    Score: 0.221
  9. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020 04 29; 12(541).
    View in: PubMed
    Score: 0.219
  10. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020 01 10; 11(1):222.
    View in: PubMed
    Score: 0.215
  11. Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis. PLoS One. 2019; 14(7):e0220126.
    View in: PubMed
    Score: 0.208
  12. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio. 2018 10 09; 9(5).
    View in: PubMed
    Score: 0.197
  13. Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines. J Virol. 2018 09 01; 92(17).
    View in: PubMed
    Score: 0.195
  14. Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice. Mamm Genome. 2018 08; 29(7-8):367-383.
    View in: PubMed
    Score: 0.195
  15. Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis. mSphere. 2017 Nov-Dec; 2(6).
    View in: PubMed
    Score: 0.185
  16. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017 06 28; 9(396).
    View in: PubMed
    Score: 0.181
  17. Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice. Cell Rep. 2021 07 27; 36(4):109450.
    View in: PubMed
    Score: 0.060
  18. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity. 2021 08 10; 54(8):1869-1882.e6.
    View in: PubMed
    Score: 0.060
  19. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. J Exp Med. 2021 03 01; 218(3).
    View in: PubMed
    Score: 0.058
  20. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature. 2021 03; 591(7850):451-457.
    View in: PubMed
    Score: 0.058
  21. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice. PLoS Pathog. 2021 01; 17(1):e1009287.
    View in: PubMed
    Score: 0.058
  22. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. JCI Insight. 2021 01 11; 6(1).
    View in: PubMed
    Score: 0.058
  23. A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine. Vaccines (Basel). 2020 Dec 17; 8(4).
    View in: PubMed
    Score: 0.057
  24. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. EBioMedicine. 2020 Dec; 62:103132.
    View in: PubMed
    Score: 0.057
  25. Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2020 11 24; 117(47):29832-29838.
    View in: PubMed
    Score: 0.057
  26. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2. Cell. 2020 11 25; 183(5):1367-1382.e17.
    View in: PubMed
    Score: 0.057
  27. High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models. Cell. 2020 10 15; 183(2):429-441.e16.
    View in: PubMed
    Score: 0.056
  28. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020 10; 586(7830):567-571.
    View in: PubMed
    Score: 0.056
  29. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice. Cell Rep. 2020 07 21; 32(3):107940.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.